During the past decade, Cancer Center Plovdiv conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cancer Center Plovdiv" are "Breast Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Cancer Center Plovdiv" in a lesser frequency.

Most popular intervention types in "Cancer Center Plovdiv" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab and Capecitabine" (1 trials), "Bevacizumab and Paclitaxel" (1 trials), "Docetaxel" (1 trials) and "Gemcitabine, Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Center Plovdiv" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cancer Center Plovdiv". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cancer Center Plovdiv, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Center Plovdiv, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".